A Comparison Between Bisphosphonates and Other Treatments for Osteoporosis

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|27|3037-3044

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.27, 2010-01, pp. : 3037-3044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonates/prednisolone/warfarin: Glucocorticoid-induced osteoporosis and various other toxicities in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1274, 2009-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Bisphosphonates in osteoporosis: recent clinical experience

By McClung M.R.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite

Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis

By Strampel William  

Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. : 755-763

Adis International

Access to resources Recommend Favorite

Treatments for postmenopausal osteoporosis reviewed

By  

Inpharma, Vol. 1, Iss. 1401, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite